Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

News

News
New Cancer-Causing Toxin Found in Recalled Blood Pressure Pills
03/01/2019
A third cancer-causing toxin was found in some blood pressure pills recalled by India's Hetero Labs Ltd, adding to a global recall of commonly used drugs to treat hypertension.
A third cancer-causing toxin was found in some blood pressure pills recalled by India's Hetero Labs Ltd, adding to a global recall of commonly used drugs to treat hypertension.
A third cancer-causing toxin was...
03/01/2019
Pharmacy Learning Network
News
Hypertension Capsules Pulled
02/28/2019
The FDA is recalling a prescription calcium channel blocker used to treat patients with hypertension and chest pain.
The FDA is recalling a prescription calcium channel blocker used to treat patients with hypertension and chest pain.
The FDA is recalling a...
02/28/2019
Pharmacy Learning Network
News
Cancer Drug Recalled
02/28/2019
A prescription alkylating agent used to treat certain types of brain cancer is being recalled.
A prescription alkylating agent used to treat certain types of brain cancer is being recalled.
A prescription alkylating agent...
02/28/2019
Pharmacy Learning Network

Advertisement

News
Anticonvulsant Recalled
02/28/2019
A Class II recall is active for a prescription anticonvulsant medication used to treat seizure disorders as well as bipolar disorder, and to prevent migraine headaches.
A Class II recall is active for a prescription anticonvulsant medication used to treat seizure disorders as well as bipolar disorder, and to prevent migraine headaches.
A Class II recall is active for...
02/28/2019
Pharmacy Learning Network
News
Hypertension Products Recalled
02/28/2019
The FDA is recalling a prescription angiotensin receptor blocker used to treat high blood pressure and to protect kidneys from diabetes-related damage.
The FDA is recalling a prescription angiotensin receptor blocker used to treat high blood pressure and to protect kidneys from diabetes-related damage.
The FDA is recalling a...
02/28/2019
Pharmacy Learning Network
News
Cholesterol Drug Recalled
02/28/2019
A prescription statin used to treat high cholesterol and coronary heart disease is being recalled.
A prescription statin used to treat high cholesterol and coronary heart disease is being recalled.
A prescription statin used to...
02/28/2019
Pharmacy Learning Network

Advertisement

News
Peanut Consumption After Immunotherapy May Lower Reaction Risk
02/26/2019
Consuming peanuts regularly after completing oral immunotherapy or sublingual immunotherapy for peanut allergy may lessen the risk of allergic reaction from accidental exposure.
Consuming peanuts regularly after completing oral immunotherapy or sublingual immunotherapy for peanut allergy may lessen the risk of allergic reaction from accidental exposure.
Consuming peanuts regularly...
02/26/2019
Pharmacy Learning Network
News
FDA Issues Boxed Warning For Gout Treatment
02/26/2019
The FDA has called for the addition of a boxed warning alerting clinicians and patients of an increased risk of cardiovascular death with the use of a gout drug.
The FDA has called for the addition of a boxed warning alerting clinicians and patients of an increased risk of cardiovascular death with the use of a gout drug.
The FDA has called for the...
02/26/2019
Pharmacy Learning Network
News
Flu Season May Play a Role in Kidney Failure Deaths
02/25/2019
Researchers recently examined how the spread of influenza-like illnesses impacted death rates among patients on dialysis.
Researchers recently examined how the spread of influenza-like illnesses impacted death rates among patients on dialysis.
Researchers recently examined...
02/25/2019
Pharmacy Learning Network

Advertisement

News
Pharmacist Follow-Up Calls Could Help Curb Repeat Hospitalizations
02/25/2019
Patients sent home from the hospital with multiple prescription drugs may be less likely to have repeat hospitalizations when they receive follow-up calls from a pharmacist.
Patients sent home from the hospital with multiple prescription drugs may be less likely to have repeat hospitalizations when they receive follow-up calls from a pharmacist.
Patients sent home from the...
02/25/2019
Pharmacy Learning Network

Advertisement

Advertisement

Advertisement

Stay Informed & Sign Up Today

Pharmacy Learning Network Newsletter

Advertisement

Video Insights

Videos
David Rubin, MD, on JAK Inhibitors: Small But Mighty
11/22/2023

Featuring David Rubin, MD

Featuring David Rubin, MD
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his...
11/22/2023
Pharmacy Learning Network
Videos
Advantages and Drawbacks of Lecanemab in Alzheimer Disease Treatment
11/10/2023

Featuring Paul Schulz, MD 

Featuring Paul Schulz, MD 
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the...
11/10/2023
Pharmacy Learning Network
Videos
Immunosuppressants or Immunomodulators? Biologic Agents for Psoriasis
10/27/2023

Featuring Ronald Vender, MD, FRCPC

Featuring Ronald Vender, MD, FRCPC ...
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Application of Dupilumab to Pediatric Patients With Atopic Dermatitis
10/27/2023

Featuring Abigail Cline, MD, PhD, FAAD

Featuring Abigail Cline, MD, PhD, FAA...
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Patient Considerations When Prescribing Lecanemab for Alzheimer Disease
10/06/2023

Featuring Paul Schulz, MD

Featuring Paul Schulz, MD
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the...
10/06/2023
Pharmacy Learning Network
Headshots of Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC
Videos
Specialty Pharmacy Next: Focus on Distribution Processes, Data Utilization, New Drugs, and More
07/18/2023

Featuring Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC

Featuring Chris Fausel, PharmD, MHA, ...
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of...
07/18/2023
Pharmacy Learning Network
Videos
Leaders in Pharmacy Come Together to Discuss and Debate Oncology-Related Developments
06/28/2021
Julie Gould
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams,...
06/28/2021
Pharmacy Learning Network
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
Videos
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
04/19/2021
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief...
04/19/2021
Pharmacy Learning Network
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
Videos
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
12/28/2020
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO,...
12/28/2020
Pharmacy Learning Network
Identifying Risks of Human Error, Workarounds in Pharmacy
Videos
Identifying Risks of Human Error, Workarounds in Pharmacy
12/22/2020
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP,...
12/22/2020
Pharmacy Learning Network

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use